The Covid-19 pandemic has opened up another regulatory divergence between the US FDA and its opposite number in the EU. While in the US the possible approval of a Covid-19 vaccine takes on increasingly political dimensions, the European Medicines Agency has already quietly begun rolling reviews of two vaccines.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,